chr6-116632449-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001010892.3(RSPH4A):c.*8A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00162 in 1,606,566 control chromosomes in the GnomAD database, including 81 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00084 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 79 hom. )
Consequence
RSPH4A
NM_001010892.3 3_prime_UTR
NM_001010892.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.40
Genes affected
RSPH4A (HGNC:21558): (radial spoke head component 4A) This gene encodes a protein that appears to be a component the radial spoke head, as determined by homology to similar proteins in the biflagellate alga Chlamydomonas reinhardtii and other ciliates. Radial spokes, which are regularly spaced along cilia, sperm, and flagella axonemes, consist of a thin 'stalk' and a bulbous 'head' that form a signal transduction scaffold between the central pair of microtubules and dynein. Mutations in this gene cause primary ciliary dyskinesia 1, a disease arising from dysmotility of motile cilia and sperm. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 6-116632449-A-G is Benign according to our data. Variant chr6-116632449-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 227053.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-116632449-A-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00084 (128/152308) while in subpopulation SAS AF= 0.0259 (125/4828). AF 95% confidence interval is 0.0222. There are 2 homozygotes in gnomad4. There are 106 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RSPH4A | NM_001010892.3 | c.*8A>G | 3_prime_UTR_variant | 6/6 | ENST00000229554.10 | NP_001010892.1 | ||
LOC124901386 | XR_007059721.1 | n.459+1356T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RSPH4A | ENST00000229554.10 | c.*8A>G | 3_prime_UTR_variant | 6/6 | 1 | NM_001010892.3 | ENSP00000229554 | P1 | ||
RSPH4A | ENST00000368581.8 | c.*220A>G | 3_prime_UTR_variant | 5/5 | 1 | ENSP00000357570 | ||||
RSPH4A | ENST00000368580.4 | downstream_gene_variant | 5 | ENSP00000357569 |
Frequencies
GnomAD3 genomes AF: 0.000834 AC: 127AN: 152190Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
127
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00351 AC: 829AN: 236254Hom.: 17 AF XY: 0.00487 AC XY: 620AN XY: 127194
GnomAD3 exomes
AF:
AC:
829
AN:
236254
Hom.:
AF XY:
AC XY:
620
AN XY:
127194
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00170 AC: 2474AN: 1454258Hom.: 79 Cov.: 31 AF XY: 0.00253 AC XY: 1830AN XY: 722490
GnomAD4 exome
AF:
AC:
2474
AN:
1454258
Hom.:
Cov.:
31
AF XY:
AC XY:
1830
AN XY:
722490
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000840 AC: 128AN: 152308Hom.: 2 Cov.: 32 AF XY: 0.00142 AC XY: 106AN XY: 74480
GnomAD4 genome
AF:
AC:
128
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
106
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
21
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 10, 2015 | c.*8A>G in RSPH4A: This variant is not expected to have clinical significance be cause it has been identified in 3% (404/12030) of South Asian chromosomes, inclu ding 7 homozygotes by the Exome Aggregation Consortium (ExAC, http://exac.broadi nstitute.org; dbSNP rs575857124). - |
Primary ciliary dyskinesia 11 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at